 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Trial completion date, Trial primary completion date, CAR T-Cell Therapy: The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer (clinicaltrials.gov) - Aug 18, 2021
P1, N=10, Recruiting, Sponsor: Shanghai 6th People's Hospital
Trial completion date: Jan 2022 --> Jan 2023 | Trial primary completion date: Jan 2021 --> Jan 2023
- | Trial completion date, Trial primary completion date, CAR T-Cell Therapy: The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer (clinicaltrials.gov) - Mar 18, 2020
P1, N=10, Recruiting, Sponsor: Shanghai 6th People's Hospital
Trial completion date: Jan 2022 --> Jan 2023 | Trial primary completion date: Jan 2021 --> Jan 2023 Trial completion date: Jan 2021 --> Jan 2022 | Trial primary completion date: Jan 2020 --> Jan 2021
- | Enrollment open, CAR T-Cell Therapy: The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer (clinicaltrials.gov) - Aug 26, 2019
P1, N=10, Recruiting, Sponsor: Shanghai 6th People's Hospital
Trial completion date: Jan 2021 --> Jan 2022 | Trial primary completion date: Jan 2020 --> Jan 2021 Not yet recruiting --> Recruiting
- | anti- MESO CAR-T cells / Hrain Biotech
Enrollment open, Trial initiation date, CAR T-Cell Therapy: MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer (clinicaltrials.gov) - Apr 10, 2019
P1, N=20, Recruiting, Sponsor: Zhejiang University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2019 --> Apr 2019
- || New P1 trial, CAR T-Cell Therapy: The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer (clinicaltrials.gov) - Jan 24, 2019
P1, N=10, Not yet recruiting, Sponsor: Shanghai 6th People's Hospital
- || anti- MESO CAR-T cells / Hrain Biotech
New P1 trial, CAR T-Cell Therapy: MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer (clinicaltrials.gov) - Jan 9, 2019
P1, N=20, Not yet recruiting, Sponsor: Zhejiang University